[系统性硬化症中的骨质疏松症治疗:日常临床实践中的挑战和策略]
Nils Schulz1, Ulf Müller-Ladner2, Philipp Klemm2
1Campus Kerckhoff, Abteilung für Rheumatologie, Immunologie, Osteologie und physikalische Medizin, Justus-Liebig-Universität Giessen, Benekestr. 2-8, 61231, Bad Nauheim, Deutschland. n.schulz@kerckhoff-klinik.de.
Zeitschrift fur Rheumatologie
|October 10, 2025
概括
系统性硬化症 (SSc) 患者的骨质疏松症和骨折风险更高. 针对疾病的具体评估和个性化治疗对于管理SSc.骨质疏松症至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 骨质疏松症研究 骨质疏松症研究
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,导致显著的发病率和死亡率.
- 骨质疏松症在SSc患者中很普遍,但往往是未被认可和不充分理解的.
- SSc通过血管病变,纤维化和炎症加剧骨质疏松症风险因素.
研究的目的:
- 审查有关SSc.骨质疏松症的现有证据.
- 涵盖流行病学,病理生理学,诊断和治疗方面的挑战.
- 突出需要SSc特定的管理策略.
主要方法:
- 从2003年到2025年对文学进行叙事审查.
- 在PubMed,Embase和指南来源中进行的搜索.
- 专注于SSc.内的骨质学的方面.
主要成果:
- 骨质疏松症患者的骨质疏松症和骨折患病率增加.
- 脊椎骨评分 (TBS) 有助于评估骨折风险.
- 胃肠道的干扰使口服双酸盐的疗效复杂化;肠道药物显示出有前途.
结论:
- 在SSc中的骨质疏松症需要量身定制的风险评估和个性化治疗.
- 基于证据的建议需要进一步的前性研究.
- 个性化方法是管理SSc相关骨病的关键.
相关概念视频
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
Nephrotic Syndrome III : Nursing Management
279
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
279
Rheumatic Heart Disease IV: Nursing Management
268
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
268
Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285
COPD: Management Using Bronchodilators and Corticosteroids
726
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
726


